Cantargia AB
Lund, Skane County, Sweden · Biopharma, Biotechnology, Health Care
Cantargia AB is a publicly traded biopharmaceutical company focused on the development of treatments for autoimmune and inflammatory diseases. The company works on innovative therapies leveraging its expertise in clinical development and regulatory strategies. It is dedicated to improving the quality of life for patients by addressing unmet medical needs.
Key facts
- Headquarters
- Lund, Skane County, Sweden
- Employees
- 22
- Industries
- Biopharma, Biotechnology, Health Care
- Status
- Private
- Website
- cantargia.com
- Company page
Recent activity at Cantargia AB
Leadership
- Hilde Steineger, Chief Executive Officer
- Morten Lind Jensen, Chief Medical Officer
Verified email and direct lines for Cantargia AB’s decision-makers are on Fundz. See plans
Cantargia AB in the news
- Cantargia to Participate in Upcoming Investor Conferences - Finansavisen (Aug 28, 2026)
- Cantargia publishes Half-Year Report 2026 - Finansavisen (Aug 19, 2026)
- Cantargia (Q2 Review): New Financing Locks In the PDAC Combination Study - TradingView (Aug 20, 2026)
- Cantargia Highlights Preclinical Data at AACR Supporting Nadunolimab in Combination with RAS Inhibition in PDAC - Yahoo Finance (Sep 30, 2026)
- Cantargia AB to Host Webcast covering Rights Issue, Loan Agreement, and Strategic Priorities - Finansavisen (May 28, 2026)
- Cantargia to host Q2 2026 Interim Results Conference Call - Finansavisen (Aug 04, 2026)
- Cantargia (OM:CANTA) - Stock Analysis - Simply Wall Street (Mar 09, 2018)
- Cantargia appoints Dr. Wolfram Dempke as Chief Medical Officer - Finansavisen (Oct 02, 2025)
Companies similar to Cantargia AB
- Dimerix Limited · Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
- Newron Pharmaceuticals S.p.A. & EA Pharma Ltd · Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
- OnCusp Therapeutics · Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
- LAVA Therapeutics · Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
- NRx Pharmaceuticals · Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
About Cantargia AB: questions and answers
What does Cantargia AB do?
Cantargia AB is a publicly traded biopharmaceutical company focused on the development of treatments for autoimmune and inflammatory diseases. The company works on innovative therapies leveraging its expertise in clinical development and regulatory strategies. It is dedicated to improving the quality of life for patients by addressing unmet medical needs.
Where is Cantargia AB headquartered?
Cantargia AB is headquartered in Lund, Skane County, Sweden.
How many employees does Cantargia AB have?
Cantargia AB has about 22 employees.
Who leads Cantargia AB?
Hilde Steineger is a Chief Executive Officer at Cantargia AB.
What is the latest news on Cantargia AB?
On Aug 18, 2025, Cantargia Appoints Dr Hilde Steineger as Chief Executive Officer
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy